Tianjin Junan Biopharmaceutical

Tianjin Junan Biopharmaceutical is a China-based biotechnology company specializing in the development of recombinant vaccines and therapeutic proteins. The company's core focus is on addressing infectious diseases, particularly those prevalent in the Asia-Pacific region, such as Hand, Foot, and Mouth Disease (HFMD). Its lead candidate is a bivalent recombinant vaccine targeting Enterovirus 71 and Coxsackievirus A16. Tianjin Junan leverages advanced protein engineering and large-scale fermentation technologies to produce high-purity biological products. The company operates research and pilot manufacturing facilities within the Tianjin Economic-Technological Development Area.